Estelle-35 ED New Zealand - English - Medsafe (Medicines Safety Authority)

estelle-35 ed

douglas pharmaceuticals limited - cyproterone acetate 2mg;  ; ethinylestradiol 0.035mg;   - film coated tablet - active: cyproterone acetate 2mg   ethinylestradiol 0.035mg   excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry buff oy-3690 opadry white y-1r-7000b opaglos white 6000 povidone purified water quinoline yellow sucrose lactose monohydrate magnesium stearate microcrystalline cellulose - estelle-35 and estelle-35 ed are indicated for the treatment of androgen dependent diseases in women, such as acne (where oral antibiotics or local treatment alone has not been successful), especially pronounced forms and those which are accompanied by seborrhoea or by inflammation or formation of nodes (acne papulopustulosa, acne nodulocystica), androgenic alopecia, mild forms of hirsutism. estelle-35 and estelle-35 ed are also indicated for oral contraception in women requiring treatment for these androgen-dependent diseases; it is not recommended in women solely for contraception. estelle-35 and estelle-35 ed are also indicated for treating the symptoms of polycystic ovary syndrome.

Dianette 2mg/35 microgram coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

dianette 2mg/35 microgram coated tablets

bayer limited - cyproterone acetate; ethinylestradiol ph.eur. - coated tablet - 2/35 milligram(s) - antiandrogens and estrogens; cyproterone and estrogen

DIANETTE 2/35 mg/mcg Coated Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

dianette 2/35 mg/mcg coated tablets

clear pharma limited - cyproterone acetate, ethinylestradiol - coated tablets - 2/35 mg/mcg - antiandrogens and estrogens

DIANE-35 TABLET Singapore - English - HSA (Health Sciences Authority)

diane-35 tablet

bayer (south east asia) pte ltd - cyproterone acetate; ethinylestradiol - tablet, sugar coated - 2 mg - cyproterone acetate 2 mg; ethinylestradiol 0.035 mg

DEPALEPT 500 ENTERIC COATED TABLETS Israel - English - Ministry of Health

depalept 500 enteric coated tablets

cts chemical industries ltd, israel - valproic acid as sodium - tablets enteric coated - valproic acid as sodium 500 mg - valproic acid - valproic acid - generalized or partial epilepsy, secondary generalized epilepsy, mixed forms of epilepsy.

DEPALEPT SYRUP Israel - English - Ministry of Health

depalept syrup

cts chemical industries ltd, israel - valproic acid as sodium - syrup - valproic acid as sodium 40 mg/ml ml - valproic acid - valproic acid - generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.

DEPALEPT 200 MG Israel - English - Ministry of Health

depalept 200 mg

cts chemical industries ltd, israel - valproic acid as sodium - tablets enteric coated - valproic acid as sodium 200 mg - valproic acid - valproic acid - anti-epileptic.

DEPALEPT ORAL SOLUTION Israel - English - Ministry of Health

depalept oral solution

cts chemical industries ltd, israel - valproic acid as sodium - solution (oral) - valproic acid as sodium 200 mg/ml - valproic acid - treatment of generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.